Related Experiment Video
Updated: Jun 16, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Diagnosis and treatment of erectile dysfunction--a practical update
1Urology Department, Saint John Emergency Clinical Hospital, Bucharest. cpersu@rdslink.ro
Journal of Medicine and Life
|January 30, 2010
Summary
Erectile dysfunction (ED) was once attributed mainly to aging or psychogenic causes. Advances in understanding penile physiology and new treatments like PDE-5 inhibitors offer improved approaches for ED patients.
Area of Science:
- Urology
- Andrology
- Men's Health
Background:
- Historically, erectile dysfunction (ED) was often linked solely to aging or psychological factors.
- Limited understanding of penile physiology restricted effective evaluation and treatment options.
- This led to significant patient concern with few therapeutic avenues.
Purpose of the Study:
- To review the evolving understanding of erectile dysfunction (ED).
- To highlight advancements in the physiological understanding of penile tumescence and detumescence.
- To discuss modern therapeutic strategies for managing ED.
Main Methods:
- Review of historical perspectives on erectile dysfunction (ED) etiology.
- Analysis of advancements in understanding the physiology of penile erection.
- Overview of contemporary treatment modalities for ED.
Main Results:
- Improved comprehension of penile tumescence and detumescence physiology.
- Development of novel therapeutic agents, including phosphodiesterase type 5 (PDE-5) inhibitors.
- Introduction of diverse treatment options, ranging from less to more invasive approaches.
Conclusions:
- The approach to erectile dysfunction (ED) has significantly advanced beyond aging and psychogenic explanations.
- Modern pharmacological and therapeutic interventions offer new hope and effective management for ED.
- Personalized treatment strategies are crucial for addressing individual patient needs in ED management.
Related Concept Videos
01:20Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
01:17Male Sexual Response: Erection & Ejaculation
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...